• Latest Posts

8 rare diseases selected for gene therapy trial portfolio

Sania Therapeutics launches to advance neural circuit dysfunction medicines

Cell and gene therapy company NewBiologix exits stealth with $50M

Delivering on the need for vector innovation in genetic medicine

Cell rejuvenation for age-related diseases

Opinion 9 May 2023

Where is innovation needed in cell therapy?


Gene & cell therapy manufacturer Ascend launches with more than $130M

How thalassemia gene therapy approval is making a difference

Gene therapy and chemotherapy could be new osteosarcoma treatment option

Life Biosciences gene therapy data shows visual function restored in primates

In Depth 18 Apr 2023

Gene therapy: a powerful tool for hemophilia B?

Complement Therapeutics raises €72M for eye condition gene therapy